Ruxolitinib inhibits the proliferation of Epstein Barr virus (EBV)-specific T cells and limits their killing efficiency in vitro
SWISS MEDICAL WEEKLY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined